Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Vanguard Tax Managed Fund FTSE Developed Markets ETF (VEA) vs Health Care Select Sector SPDR Fund (XLV) Price & Performance

Vanguard Tax Managed Fund FTSE Developed Markets ETFTrade
Health Care Select Sector SPDR FundTrade

Price performance (Past 24H)

Key statistics

Vanguard Tax Managed Fund FTSE Developed Markets ETF vs Health Care Select Sector SPDR Fund — how do they compare? Vanguard Tax Managed Fund FTSE Developed Markets ETF trades at $73.3, while Health Care Select Sector SPDR Fund trades at $168.42. Which is the better fit depends on your goals.

VEAXLV
52-Week High
$72.89$168.44
52-Week Low
$58.19$131.16

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

Vanguard Tax Managed Fund FTSE Developed Markets ETF

VEA trades at $73.30, up 1.1% with a bullish technical signal from moving averages. The ETF shows mixed institutional activity with recent buying from Ferguson Shapiro and selling from Financial Advisory Corp. Technical indicators show overbought RSI conditions while maintaining strong momentum with ADX at 47.42. The fund offers international diversification with a low expense ratio of 0.03% and upcoming dividend payment.

VEA presents a compelling international diversification opportunity with strong technical momentum and cost efficiency. However, overbought conditions and mixed institutional sentiment suggest potential near-term volatility. The fund's focus on developed markets outside the US provides geographic diversification but remains exposed to global economic headwinds and currency fluctuations.

Health Care Select Sector SPDR Fund

XLV, the Health Care Select Sector SPDR ETF, trades at $168.44 with a neutral daily change. Technical indicators show a bullish trend from moving averages but oscillators are neutral, with the 6-day RSI at 86.78 suggesting overbought conditions. The fund's low 0.08% expense ratio and defensive healthcare sector exposure attract steady inflows amid market volatility, as highlighted by recent ETF flow reports.

The outlook for XLV is cautiously optimistic, supported by defensive demand and strong sector earnings. Key opportunities include diversification benefits and cost efficiency, while risks involve sector-specific regulatory pressures and broader economic sensitivity. Investors should weigh the ETF's stability against potential growth limitations in a concentrated portfolio.

Returns comparison

Trailing returns across standard periods

Top news

Latest headlines on both assets

About Vanguard Tax Managed Fund FTSE Developed Markets ETF

The fund employs an indexing investment approach designed to track the performance of the FTSE Developed All Cap ex US Index, a market-capitalization-weighted index that is made up of approximately 4022 common stocks of large-, mid-, and small-cap companies located in Canada and the major markets of Europe and the Pacific region. The advisor attempts to replicate the target index by investing all, or substantially all, of its assets in the stocks that make up the index, holding each stock in approximately the same proportion as its weighting in the index.

Read more on VEA

About Health Care Select Sector SPDR Fund

In seeking to track the performance of the index, the fund employs a replication strategy. It generally invests substantially all, but at least 95%, of its total assets in the securities comprising the index. The index includes companies from the following industries: pharmaceuticals; health care equipment & supplies; health care providers & services; biotechnology; life sciences tools & services; and health care technology. The fund is non-diversified.

Read more on XLV